Crescent Capital BDC, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 9, 2026, disclosing consolidated balance sheet data and portfolio investment values as of that date.

Key Highlights

  • Shares outstanding: 36,845,952 shares of common stock were outstanding as of November 9, 2026, according to the filing.
  • Non-controlled non-affiliated investments: Fair value of $1,465,353 thousand as of September 30, 2026, against a cost of $1,509,464 thousand.
  • Non-controlled affiliated investments: Fair value of $30,884 thousand as of September 30, 2026, against a cost of $30,735 thousand.
  • Controlled investments: Fair value of $58,915 thousand as of September 30, 2026, against a cost of $71,310 thousand.
  • Cash and cash equivalents: $12,081 thousand as of September 30, 2026, compared to $5,043 thousand as of December 31, 2025.
  • Restricted cash and cash equivalents: $24,123 thousand as of September 30, 2026, down from $26,454 thousand as of December 31, 2025.
  • Filer status: The registrant is classified as an accelerated filer and is not a shell company, according to the filing.

Crescent Capital BDC's September 30, 2026 Portfolio and Balance Sheet Positions

Crescent Capital BDC, Inc. (NASDAQ:CCAP), a Maryland-incorporated business development company headquartered at 11100 Santa Monica Blvd., Suite 2000, Los Angeles, CA 90025, submitted its quarterly report covering the period ended September 30, 2026. The filing covers consolidated financial statements, management's discussion and analysis, and other required disclosures under the Securities Exchange Act of 1934.

According to the consolidated statements of assets and liabilities, the company's total investment portfolio at fair value as of September 30, 2026 consisted of non-controlled non-affiliated investments valued at $1,465,353 thousand (cost: $1,509,464 thousand), non-controlled affiliated investments valued at $30,884 thousand (cost: $30,735 thousand), and controlled investments valued at $58,915 thousand (cost: $71,310 thousand). By comparison, the same categories were carried at fair values of $1,479,473 thousand, $29,594 thousand, and $60,351 thousand, respectively, as of December 31, 2025, the filing disclosed.

The filing also reported an interest and dividend receivable balance of $7,672 thousand as of September 30, 2026, compared to $9,333 thousand as of December 31, 2025. The company noted that forward-looking statements contained in the report "are not historical facts" and are subject to risks and uncertainties; it further stated that "the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, which preclude civil liability for certain forward-looking statements, do not apply to the forward-looking statements in this report because we are an investment company."

What Was Disclosed

Crescent Capital BDC filed its 10-Q for Q3 2026, reporting consolidated investment fair values, cash positions, and share count as of September 30, 2026, alongside comparative figures from December 31, 2025. The filing is for the quarterly period ended September 30, 2026.